ES2389775T3 - Producción y purificación de la proteína A sin emplear componentes de origen animal - Google Patents
Producción y purificación de la proteína A sin emplear componentes de origen animal Download PDFInfo
- Publication number
- ES2389775T3 ES2389775T3 ES06253985T ES06253985T ES2389775T3 ES 2389775 T3 ES2389775 T3 ES 2389775T3 ES 06253985 T ES06253985 T ES 06253985T ES 06253985 T ES06253985 T ES 06253985T ES 2389775 T3 ES2389775 T3 ES 2389775T3
- Authority
- ES
- Spain
- Prior art keywords
- vegetable protein
- protein
- eluent
- column
- resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US194093 | 2005-07-29 | ||
| US11/194,093 US7375188B2 (en) | 2005-07-29 | 2005-07-29 | Vegetarian protein a preparation and methods thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2389775T3 true ES2389775T3 (es) | 2012-10-31 |
Family
ID=36954658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES06253985T Expired - Lifetime ES2389775T3 (es) | 2005-07-29 | 2006-07-31 | Producción y purificación de la proteína A sin emplear componentes de origen animal |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7375188B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1748063B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007039454A (cg-RX-API-DMAC7.html) |
| ES (1) | ES2389775T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL1748063T3 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY185597A (en) * | 2005-09-20 | 2021-05-24 | Avantor Performance Mat Inc | Vegetarian protein a preparation and methods thereof |
| PL2117587T3 (pl) | 2007-03-05 | 2018-07-31 | Om Pharma | Ekstrakt bakteryjny przeznaczony do stosowania względem zaburzeń układu pokarmowego lub moczowego i sposób jego wytwarzania |
| ES2761697T3 (es) * | 2008-08-28 | 2020-05-20 | Novartis Ag | Proceso para preparar una emulsión de aceite en agua que contiene escualeno procedente de levaduras |
| EP2814514B1 (en) | 2012-02-16 | 2017-09-13 | Atyr Pharma, Inc. | Histidyl-trna synthetases for treating autoimmune and inflammatory diseases |
| CN114717206A (zh) | 2013-03-15 | 2022-07-08 | Atyr 医药公司 | 组氨酰-trna合成酶-fc缀合物 |
| JP6404821B2 (ja) * | 2013-09-12 | 2018-10-17 | 国立大学法人 岡山大学 | インターロイキン10産生促進剤 |
| ES2994451T3 (en) | 2017-04-20 | 2025-01-24 | Atyr Pharma Inc | Compositions for treating lung inflammation |
| CN106977591B (zh) * | 2017-05-04 | 2020-05-05 | 广州康盛生物科技股份有限公司 | 一种分离纯化重组葡萄球菌蛋白a的方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3625833A (en) * | 1970-01-23 | 1971-12-07 | James J Schaffer | Process for producing antiviral substance from staphylococcus organisms |
| US4464165A (en) * | 1980-11-24 | 1984-08-07 | American Hoechst Corporation | Material and method for removing immunoglobulins from whole blood |
| US5151350A (en) * | 1982-10-27 | 1992-09-29 | Repligen Corporation | Cloned genes encoding recombinant protein a |
| SE8300693L (sv) * | 1983-02-09 | 1984-08-10 | Sven Lofdahl | Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta |
| US4699783A (en) * | 1983-03-11 | 1987-10-13 | Terman David S | Products and methods for treatment of cancer |
| US4617266A (en) | 1983-04-28 | 1986-10-14 | Genex Corporation | Production of Protein A |
| JPS61224997A (ja) | 1985-03-29 | 1986-10-06 | Chemo Sero Therapeut Res Inst | プロテインaの精製方法 |
| US4801687A (en) * | 1986-10-27 | 1989-01-31 | Bioprobe International, Inc. | Monoclonal antibody purification process using protein A |
| EP0289129A3 (en) | 1987-03-26 | 1990-10-10 | Repligen Corporation | High purity protein a preparation |
| ATE91152T1 (de) * | 1988-07-22 | 1993-07-15 | Imre Corp | Gereinigte protein a-zusammensetzungen und verfahren zu ihrer herstellung. |
| US6555661B1 (en) * | 1997-08-25 | 2003-04-29 | Anthony R. Torres | Simple, environmentally benign, method for purifying protein A |
| US5902722A (en) * | 1997-12-05 | 1999-05-11 | The Perkin-Elmer Corporation | Method of detecting organisms in a sample |
| US6406909B1 (en) * | 1998-07-10 | 2002-06-18 | Chugai Seiyaku Kabushiki Kaisha | Serum-free medium for culturing animal cells |
| AT409379B (de) * | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
| JP4363986B2 (ja) | 2001-12-21 | 2009-11-11 | イミュネックス・コーポレーション | タンパク質の精製方法 |
| US20040235139A1 (en) * | 2002-12-23 | 2004-11-25 | Demain Arnold L. | Clostridium difficile culture and toxin production methods |
| EP1692269A4 (en) * | 2003-12-12 | 2007-09-26 | Sanofi Pasteur Ltd | PRODUCTION OF DIPHTHERIA TOXIN |
| US20050282294A1 (en) * | 2004-06-17 | 2005-12-22 | Lothar Britsch | Affinity supports with immobilised protein A |
| MY185597A (en) * | 2005-09-20 | 2021-05-24 | Avantor Performance Mat Inc | Vegetarian protein a preparation and methods thereof |
-
2005
- 2005-07-29 US US11/194,093 patent/US7375188B2/en not_active Expired - Fee Related
-
2006
- 2006-07-28 JP JP2006205679A patent/JP2007039454A/ja active Pending
- 2006-07-31 EP EP06253985A patent/EP1748063B1/en not_active Expired - Lifetime
- 2006-07-31 PL PL06253985T patent/PL1748063T3/pl unknown
- 2006-07-31 ES ES06253985T patent/ES2389775T3/es not_active Expired - Lifetime
-
2008
- 2008-03-12 US US12/046,582 patent/US20090060904A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007039454A (ja) | 2007-02-15 |
| EP1748063A1 (en) | 2007-01-31 |
| US20070026489A1 (en) | 2007-02-01 |
| PL1748063T3 (pl) | 2012-11-30 |
| US20090060904A1 (en) | 2009-03-05 |
| EP1748063B1 (en) | 2012-06-27 |
| US7375188B2 (en) | 2008-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI111336B (fi) | Menetelmä Staphylococcus epidermidis tyyppi I:n polysakkaridiantigeenin sisältävän rokotteen ja antigeeninvastaisen hyperimmunoglobuliinin valmistamiseksi | |
| AU585200B2 (en) | Monoclonal antibodies reactive with endotoxin core | |
| Kfir et al. | Monoclonal antibody specific for cyanoginosin-LA: preparation and characterization | |
| US20090060904A1 (en) | Vegetarian Protein A Preparation and Methods Thereof | |
| CN102458478B (zh) | 白蛋白-淀粉样肽缀合物及其用途 | |
| WO2007035341A1 (en) | Protein a production and purification without using animal derived components | |
| ES2235228T3 (es) | Procedimiento de purificacion de la toxina cm 101 del grupo gbs. | |
| JPH01190635A (ja) | 抗体およびそれを有効成分とするう蝕予防剤、並びにこれらの製造方法 | |
| CA2005119A1 (en) | Use of basic amino acids to solubilize immunoglobulins | |
| WO1989010133A1 (en) | Stem cell inhibitors | |
| ES2325584T3 (es) | Purificacion de variantes de her-2. | |
| EP1370289A2 (de) | Verfahren zur herstellung eines autologen antikörpers enthaltenden impfstoffes | |
| CN107216369A (zh) | 一种鱼精蛋白类似活性肽及其制备方法与应用 | |
| CN117024564A (zh) | 一种多肽改造体及其在制备抗炎杀菌药物中的应用 | |
| CN115819624B (zh) | 一种重组融合蛋白及其制备方法和应用 | |
| CN105218660B (zh) | 重组内皮抑素的新型纯化复性方法及其抗肿瘤应用 | |
| ES3062256A2 (es) | METODOS DE PRODUCCION DE COMPOSICIONES QUE COMPRENDEN NEUROTOXINA DE CLOSTRIDIUM BOTULINUM SEROTIPO A (BoNT/A) | |
| WO2003007874A2 (en) | Anti-tumor activity from reptile serum | |
| SU663714A1 (ru) | Способ получени анатоксина | |
| JPH03173899A (ja) | 生体由来のタンパク質 | |
| CN114404614A (zh) | 一种靶向铜绿假单胞菌的免疫脂质体及其制备方法和应用 | |
| JPH01247096A (ja) | モノクローナル抗体の回収方法 | |
| PT92040A (pt) | Processo para isolamento de interleucemia-2 glicosilada | |
| TH160179A (th) | การทำไอดิลโรเนต-2-ซัลฟาเตสให้บริสุทธิ์ |